Recent Price Movement and Volatility
On 21 Jan 2026, Tarsons Products Ltd recorded its lowest-ever price at Rs.197.1, continuing a downward trajectory that has spanned multiple sessions. Over the last four trading days, the stock has declined by 9.09%, despite a modest 0.35% gain on the day, which outperformed the Sensex’s slight dip of 0.05%. The stock’s trading range remained narrow at Rs.1.75, yet it exhibited high intraday volatility of 83.7%, indicating significant price fluctuations within the session.
Technical indicators reveal that the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This persistent weakness across multiple timeframes highlights the entrenched nature of the downtrend.
Comparative Performance Against Benchmarks
Tarsons Products Ltd’s performance over various time horizons starkly contrasts with broader market indices. Over the past year, the stock has delivered a negative return of 49.60%, while the Sensex has appreciated by 8.31%. The divergence is even more pronounced over three years, with the stock falling 71.35% against a Sensex gain of 35.50%. The stock has also failed to generate any returns over five and ten years, remaining flat at 0.00%, whereas the Sensex has surged by 65.53% and 242.80% respectively over these periods.
Shorter-term metrics also reflect underperformance. Year-to-date, the stock is down 14.55%, compared to a 3.61% decline in the Sensex. Over one month and three months, the stock has fallen 13.57% and 31.18% respectively, while the Sensex has declined by 3.28% and 2.70% over the same periods.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Financial Metrics and Profitability Trends
The company’s financial performance has shown a downward trend in key profitability metrics. Operating profit has contracted at an annualised rate of 18.84% over the past five years, signalling challenges in sustaining growth. The latest six-month period ending September 2025 reported a Profit After Tax (PAT) of Rs.5.10 crore, reflecting a decline of 64.36% compared to prior periods.
Return on Capital Employed (ROCE) for the half-year stands at a low 6.69%, indicating limited efficiency in generating returns from capital investments. The debt-equity ratio has increased to 0.41 times, the highest recorded in recent periods, suggesting a moderate rise in leverage.
Institutional Investor Activity
Institutional investors have reduced their holdings by 3.44% in the previous quarter, now collectively owning only 2.47% of the company’s shares. This decline in institutional participation may reflect a reassessment of the company’s fundamentals by investors with greater analytical resources.
Valuation and Debt Servicing
Despite the challenges, Tarsons Products Ltd maintains a relatively strong capacity to service its debt obligations, with an average EBIT to interest coverage ratio of 12.03. The company’s valuation metrics suggest a fair assessment, with a ROCE of 3.9 and an enterprise value to capital employed ratio of 1.4. The stock currently trades at a discount relative to its peers’ historical valuations, reflecting market caution.
Profitability has also declined over the past year, with profits falling by 30%, aligning with the stock’s negative return of 49.60% during the same period.
Tarsons Products Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Mojo Score and Ratings
MarketsMOJO assigns Tarsons Products Ltd a Mojo Score of 31.0, categorising it with a Sell grade as of 20 Jan 2026. This represents an upgrade from a previous Strong Sell rating, indicating a slight improvement in outlook, though the overall assessment remains cautious. The company’s market capitalisation grade is rated at 3, reflecting its relative size and liquidity within the Healthcare Services sector.
Sector Context and Market Position
Operating within the Healthcare Services sector, Tarsons Products Ltd’s recent underperformance contrasts with broader sector trends. The stock has outperformed its sector by 0.63% on the day of the all-time low, yet its longer-term returns remain subdued. The persistent decline over multiple years and the stock’s inability to keep pace with benchmark indices highlight the challenges faced in maintaining competitive positioning.
Summary of Key Performance Indicators
To summarise, Tarsons Products Ltd’s key indicators as of January 2026 are as follows:
- All-time low price: Rs.197.1
- Four-day consecutive decline: -9.09%
- Intraday volatility: 83.7%
- One-year return: -49.60%
- Five-year operating profit CAGR: -18.84%
- Latest six-month PAT: Rs.5.10 crore, down 64.36%
- ROCE (half-year): 6.69%
- Debt-equity ratio (half-year): 0.41 times
- Institutional holding: 2.47%, down 3.44% from previous quarter
- Mojo Score: 31.0 (Sell grade)
The stock’s performance and financial metrics collectively illustrate a company experiencing a prolonged period of subdued growth and market valuation pressures.
Unlock special upgrade rates for a limited period. Start Saving Now →
